{
  "trial_id": "NCT03439462",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, liver function (total bilirubin, AST, ALT), renal function (serum creatinine, creatinine clearance), absolute neutrophil count (ANC), platelet count, hemoglobin, fasting serum triglyceride, fasting serum cholesterol, INR, PTT, prior chemotherapy status, measurable disease status, life expectancy, pregnancy status (for females), use of contraception, history of allergic reactions to bevacizumab, history of CNS metastases, cardiac health status, lung function, diabetes status, infection status, liver disease status, history of interstitial lung disease or pneumonitis, HIV status, Hepatitis B or C status, bleeding diathesis, use of CYP3A4 inhibitors or inducers.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "pregnancy status (for females)"
        ],
        [
          "Male",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "liver function (total bilirubin, AST, ALT)",
        "renal function (serum creatinine, creatinine clearance)",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "hemoglobin",
        "fasting serum triglyceride",
        "fasting serum cholesterol",
        "INR",
        "PTT",
        "prior chemotherapy status",
        "measurable disease status",
        "life expectancy",
        "use of contraception",
        "history of allergic reactions to bevacizumab",
        "history of CNS metastases",
        "cardiac health status",
        "lung function",
        "diabetes status",
        "infection status",
        "liver disease status",
        "history of interstitial lung disease or pneumonitis",
        "HIV status",
        "Hepatitis B or C status",
        "bleeding diathesis",
        "use of CYP3A4 inhibitors or inducers"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, ECOG performance status, Liver function (Total bilirubin, AST, ALT), Renal function (Serum creatinine, Creatinine clearance), Absolute neutrophil count (ANC), Platelet count, Hemoglobin, Fasting serum triglyceride, Fasting serum cholesterol, INR, PTT, History of prior chemotherapy, History of prior radiation therapy, History of prior surgery, Life expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "Liver function (Total bilirubin, AST, ALT)",
        "Renal function (Serum creatinine, Creatinine clearance)",
        "Absolute neutrophil count (ANC)",
        "Platelet count",
        "Hemoglobin",
        "Fasting serum triglyceride",
        "Fasting serum cholesterol",
        "INR",
        "PTT",
        "History of prior chemotherapy",
        "History of prior radiation therapy",
        "History of prior surgery",
        "Life expectancy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, BMI, Prior Chemotherapy, Prior Radiation Therapy, Prior Adjuvant Therapy, Number of Metastatic Sites, Liver Function Tests, Renal Function Tests, Hemoglobin, Absolute Neutrophil Count, Platelet Count, Fasting Serum Triglyceride, Fasting Serum Cholesterol, INR, PTT.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "ECOG Performance Status",
        "BMI",
        "Prior Chemotherapy",
        "Prior Radiation Therapy",
        "Prior Adjuvant Therapy",
        "Number of Metastatic Sites",
        "Liver Function Tests",
        "Renal Function Tests",
        "Hemoglobin",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Fasting Serum Triglyceride",
        "Fasting Serum Cholesterol",
        "INR",
        "PTT"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, primary tumor location, metastatic sites, prior adjuvant chemotherapy, prior radiation therapy, time from diagnosis to metastatic disease, time from prior chemotherapy to study entry, baseline laboratory values (hemoglobin, ANC, platelet count, AST, ALT, total bilirubin, creatinine, triglycerides, cholesterol), baseline tumor measurements (RECIST v1.1).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "primary tumor location",
        "metastatic sites",
        "prior adjuvant chemotherapy",
        "prior radiation therapy",
        "time from diagnosis to metastatic disease",
        "time from prior chemotherapy to study entry",
        "baseline laboratory values (hemoglobin, ANC, platelet count, AST, ALT, total bilirubin, creatinine, triglycerides, cholesterol)",
        "baseline tumor measurements (RECIST v1.1)"
      ]
    }
  }
}